Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
24 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
MACO - PHARMA BENELUX from Mouscron, company number BE0448280649, closed financial year 2025 with a result of € 73,268 after tax. For that financial year MACO - PHARMA BENELUX recorded revenue of € 3.7 million and equity of € 3.1 million. Compared with financial year 2024, the result moved from € 619,867 to € 73,268. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ 3.1 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 73,268
▼ 88% vs 2024
Profit after tax over the fiscal year.
€ 22,106
▼ 65% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 73,268 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
5
Average over the fiscal year, from the social balance sheet.
€ 579,788
▼ 1% vs 2024
€ 116,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,014
▼ 39% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 816,008
▲ 50% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 98 days on average.
€ 250,941
▲ 6% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 3,756,869 | € 3,812,236 | € 3,642,491 | € 3,683,067 | ▲ 1% |
| Profit after taxes | € 20,049 | € 49,600 | € 619,867 | € 73,268 | ▼ 88% |
| Equity | € 3,050,723 | € 3,050,723 | € 3,050,723 | € 3,050,723 | |
| Total debts | € 731,826 | € 788,230 | € 1,398,955 | € 1,140,217 | ▼ 18% |
| Cash | € 32,120 | € 77,328 | € 63,702 | € 22,106 | ▼ 65% |
| Retained profit | € 2,988,723 | € 2,988,723 | € 2,988,723 | € 2,988,723 | |
| Dividend | € 20,049 | € 49,600 | € 619,867 | € 73,268 | ▼ 88% |
| Balance sheet total | € 3,862,657 | € 3,929,953 | € 4,449,678 | € 4,190,940 | ▼ 6% |
| Employees (FTE) | 5 | 5 | 5 | 5 |
Key figures of MACO - PHARMA BENELUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MACO - PHARMA BENELUX?
What happened at MACO - PHARMA BENELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 73,268 (▼ 88% vs 2024). Source: NBB ↗
- New establishment in Mouscron. KBO
- Start of the company according to the CBE. KBO
In short
From € 20,049 profit in 2022 to € 73,268 profit in 2025.
Paid € 99,576 in corporate taxes since 2022.
Best year ever: 2024, with € 619,867 profit.
Paid out € 762,784 in dividends to the owners in total.
A new publication or filing at MACO - PHARMA BENELUX? We notify you, reason included.
Follow MACO - PHARMA BENELUXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Schermutselingstraat 1
7700 Mouscron
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 24 companies are registered at this address.
All companies at this address →Biral Lubricants
€ 67,105 gross margin · 2025
BUREAU CNOCKAERT
€ 465,862 gross margin · 2025
PLANNING
€ 100,975 gross margin · 2024
Chauffage Damien Corne
€ 71,636 gross margin · 2025
SODIFIL
€ 843,075 revenue · 2023
+19 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0448.280.649
- VAT number
- BE 0448.280.649
- Registered office
- Schermutselingstraat 1, 7700 Mouscron
- Names & denominations
- MACO - PHARMA BENELUX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 September 1992
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Vervaardiging van geneesmiddelen